ArticleBMC pharmacology & toxicology2025

Melatonin enhances everolimus efficacy in breast cancer by suppressing mTOR pathway activation and promoting apoptosis and mitochondrial function.

Şeyma Demirkesen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.